BMY - Bristol-Myers Squibb

BMY trying to come up for air – The worst of the peers

Bristol Myers Squibb is a global specialty biopharmaceutical company focusing on diseases such as oncology, cardiovascular, immunoscience, and hematology. The company’s acquisition of Celgene has further strengthened its position expanding its oncology and immunoscience portfolios. About 58% of Bristol Myers’ … Read more

PFE - Pfizer

Pfizer – Not Keeping Up With The Competition

Pfizer is a global biopharmaceutical giant dealing in the manufacture and development of healthcare products. It is one of the largest global pharmaceutical companies with more than $50 billion in revenues. The company has a presence across major therapeutic areas … Read more

MRK - Merck

A Solid Pharma with a Diversified Pipeline

Merck & Co. is a global innovative healthcare company with a rich history of nearly 130 years. The company provides a wide range of prescription medicines, vaccines, biologic therapies, and animal health products. Merck’s operations are managed through four segments, … Read more

CAH - Cardinal Health Inc

Ouch! Good Yield but Poor Performance for Cardinal Health

Cardinal Health Inc. is a global, integrated healthcare solutions provider. It is a leading distributor of pharmaceutical and medical products to pharmacies, hospitals, and other healthcare providers in more than 60 countries including the US, Canada, and European and Asian … Read more

ABT - Abbott Laboratories

Abbott – Recovered and Making New Highs

Abbott Laboratories is a leading global healthcare and research company having a presence in more than 160 countries. Over 14 million people around the world use Abbott’s medicines every day. With over 130 years in business, Abbott has become the … Read more

JNJ - Johnson & Johnson

Steady and Solid Dividends from J&J

Johnson & Johnson is one of the leading healthcare companies in the world, with over one billion people using its products daily. The company has a well-diversified global footprint with the US accounting for 50% of the company’s revenues, and … Read more

SYK - Stryker

Consider Stryker as a Strong Dividend Growth Stock

Stryker is a leading medical technology company in the world. The company offers innovative products and services in orthopaedics, medical and surgical, and neurotechnology and spine segments. It is a leader in creating products that make surgery more efficient, reduce … Read more